<DOC>
	<DOCNO>NCT01951469</DOCNO>
	<brief_summary>This multi-center phase II randomize control study ass efficacy Gefitinib alone Gefitinib combinating Pemetrexed/cisplatin patient brain metastasis non-small cell lung cancer ( NSCLC ) harbor EGFR mutation type intracranial PFS ( iPFS ) , also PFS , DCR OS.The side effect evaluate well .</brief_summary>
	<brief_title>Gefitinib With Without Pemetrexed/Cisplatin Brain Metastases From Non-small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Gefitinib</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>1 . Patient confirm stage IV NSCLC EGFR activate mutation brain metastasis pathologic histology cytology 2 . Patients never receive therapy ( include chemotherapy , WBRT , EGFRTKI EGFR monoclonal antibody ) diagnose brain metastasis 3 . Appraisable disease , presence least three lesion longest diameter &lt; 10 mm brain MRI 4 . Adult patient ( ≥ 18 year ≤75 year ) . ECOG Performance Status 0 1 Life expectancy least 12 weeks. , Haemoglobin ³ 10.0 g/dl , Absolute neutrophil count ( ANC ) ³1.5 x 109/L , platelet ³ 100 x 109/L . Total bilirubin £ 1.5 x upper limit normal ( ULN ) . ALT AST &lt; 2.5 x ULN absence liver metastasis , &lt; 5 x ULN case liver metastasis . Creatinine clearance ³ 60ml/min ( calculate accord Cockcroftgault formula ) . 5 . Patients contraceptive period trial 8 week last administration icotinib . 6 . Able comply require protocol followup procedure , able receive oral medication . 1 . Patient receive irradiation brain . Patient meningeal metastasis confirm MRI cytology test cerebrospinal fluid . 2 . Patient receive treatment Phenytoin , carbamazepine , rifampicin , phenobarbital , St. John 's Wort . 3 . Patient receive EGFR Tyrosine Kinase Inhibitor EGFR monoclonal antibody . 4 . Interstitial pneumonia.Pericardial effusion , pleural effusion uncontrolled . 5 . Any unstable systemic disease ( include active infection , uncontrolled hypertension , unstable angina , congestive heart failure , myocardial infarction within previous year , serious cardiac arrhythmia require medication , hepatic , renal , metabolic disease ) . 6 . Any significant ophthalmologic abnormality , especially severe dry eye syndrome , keratoconjunctivitis sicca , Sjogren syndrome , severe exposure keratitis disorder likely increase risk corneal epithelial lesion . 7 . Lack physical integrity upper gastrointestinal tract , malabsorption syndrome , inability take oral medication , active peptic ulcer disease . 8 . The symptom increase intracranial pressure uncontrolled dehydration cortisone treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>